Michael P. Manos

Statistics

Publications

Citations

5.6K

H-Index

Active since

2008

Affiliations

Dana-Farber Cancer Institute(Current)

Brigham and Women's Hospital

Harvard University

Massachusetts General Hospital

Broad Institute

Michael P. Manos is an author at Dana-Farber Cancer Institute specializing in oncology, checkpoint inhibitor therapy, and immune checkpoint inhibitors.

ORCID

Publications per year

2008–2025

Publications

Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade

Brian C. Miller, Debattama R. Sen, Rose Al Abosy et al. · Nature Immunology · 2019 · 2.1K citations · Full text

Life Sciences, Immunology, Oncology +14

Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors

Diana Miao, Claire A. Margolis, Natalie I. Vokes et al. · Nature Genetics · 2018 · 696 citations · Full text

Medicine, Genetics, Oncology +16

Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy

Adrienne Luoma, Shengbao Suo, Hannah L. Williams et al. · Cell · 2020 · 480 citations · Full text

Medicine, Immunology, Oncology +16

Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade

Jun Zhou, Kathleen M. Mahoney, Anita Giobbie‐Hurder et al. · Cancer Immunology Research · 2017 · 362 citations · Full text

Life Sciences, Immunology, Oncology +17

Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade

Shengqing Gu, Wubing Zhang, Xiaoqing Wang et al. · Cancer Discovery · 2021 · 282 citations · Full text

Life Sciences, Immunology, Oncology +16

1–5 of 29